Human Umbilical Cord Mesenchymal-Stem-Cell-Derived Extracellular Vesicles Reduce Skin Inflammation In Vitro

Int J Mol Sci. 2023 Dec 4;24(23):17109. doi: 10.3390/ijms242317109.

Abstract

The protective roles of extracellular vesicles derived from human umbilical cord mesenchymal stem cells against oxazolone-induced damage in the immortalized human keratinocyte cell line HaCaT were investigated. The cells were pretreated with or without UCMSC-derived extracellular vesicles 24 h before oxazolone exposure. The pretreated UVMSC-EVs showed protective activity, elevating cell viability, reducing intracellular ROS, and reducing the changes in the mitochondrial membrane potential compared to the cells with a direct oxazolone treatment alone. The UCMSC-EVs exhibited anti-inflammatory activity via reducing the inflammatory cytokines IL-1β and TNF-α. A mechanism study showed that the UCMSC-EVs increased the protein expression levels of SIRT1 and P53 and reduced P65 protein expression. It was concluded that UVMSC-EVs can induce the antioxidant defense systems of HaCaT cells and that they may have potential as functional ingredients in anti-aging cosmetics for skin care.

Keywords: NF-κB; SIRT1; extracellular vesicle; p53; umbilical-cord-derived mesenchymal stem cells.

MeSH terms

  • Extracellular Vesicles* / metabolism
  • Humans
  • Inflammation / metabolism
  • Mesenchymal Stem Cells* / metabolism
  • Oxazolone
  • Umbilical Cord

Substances

  • Oxazolone